Anisotropic colloidal quasi-two-dimensional
nanoplates (NPLs) hold
great promise as functional materials due to their combination of
low dimensional optoelectronic properties and versatility through
colloidal synthesis. Recently, lead-halide perovskites have emerged
as important optoelectronic materials with excellent efficiencies
in photovoltaic and light-emitting applications. Here we report the
synthesis of quantum confined all inorganic cesium lead halide nanoplates
in the perovskite crystal structure that are also highly luminescent
(PLQY 84%). The controllable self-assembly of nanoplates either into
stacked columnar phases or crystallographic-oriented thin-sheet structures
is demonstrated. The broad accessible emission range, high native
quantum yields, and ease of self-assembly make perovskite NPLs an
ideal platform for fundamental optoelectronic studies and the investigation
of future devices.
We demonstrate postsynthetic modification of CsPbBr nanocrystals by a thiocyanate salt treatment. This treatment improves the quantum yield of both freshly synthesized (PLQY ≈ 90%) and aged nanocrystals (PLQY ≈ 70%) to within measurement error (2-3%) of unity, while simultaneously maintaining the shape, size, and colloidal stability. Additionally, the luminescence decay kinetics transform from multiexponential decays typical of nanocrystalline semiconductors with a distribution of trap sites, to a monoexponential decay, typical of single energy level emitters. Thiocyanate only needs to access a limited number of CsPbBr nanocrystal surface sites, likely representing under-coordinated lead atoms on the surface, in order to have this effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.